Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Forane

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 34Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Parnell Expands Veterinary Anesthesia Portfolio With Isoflurane
    Parnell Expands Veterinary Anesthesia Portfolio With Isoflurane

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106461468/en/Parnell-Expands-Veterinary-Anesthesia-Portfolio-with-Isoflurane

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Shandong’s Generics Isoflurane Receives Approval in US
    Shandong’s Generics Isoflurane Receives Approval in US

    04 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216527

    FDA
    04 Nov 2025
    Share Share
    Sedana Medical phase III study of IsoConDa meets primary endpoint
    Sedana Medical phase III study of IsoConDa meets primary endpoint

    13 Jul 2020

    // PHARMABIZ

    http://pharmabiz.com/NewsDetails.aspx?aid=129549&sid=2

    PHARMABIZ
    13 Jul 2020
    Share Share
    Tedor Pharma Withdrawal of Approval of 10 Abbreviated New Drug Applications
    Tedor Pharma Withdrawal of Approval of 10 Abbreviated New Drug Applications

    08 Nov 2018

    // FDA

    https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-24605.pdf

    FDA
    08 Nov 2018
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.